Aris Tantisith

Aris Tantisith leads Bumrungrad International Hospital, one of the most recognized healthcare brands globally and a pioneer of the medical tourism industry. Located in central Bangkok, Bumrungrad treats over 1 million patients annually, with approximately 40% coming from outside Thailand — from over 190 countries, with particular strength in patients from the Middle East, South Asia, Myanmar, Cambodia, and other Southeast Asian nations. Bumrungrad offers comprehensive medical services across virtually every specialty, with particular renown for cardiology, orthopedics, oncology, and wellness/check-up programs. The hospital is JCI-accredited (the gold standard for international hospitals) and employs physicians trained at top international medical schools. The value proposition is compelling: world-class medical care at 50-80% lower cost than equivalent treatment in the US, UK, or Singapore. The medical tourism market has grown significantly post-COVID, with aging populations in wealthy countries, long waiting times in public healthcare systems, and rising healthcare costs driving patients to seek treatment abroad. Bumrungrad has also expanded through management contracts and partnerships with hospitals in other countries. Key stock drivers include international patient volumes, medical tourism growth, Thai tourism recovery, payor mix, average revenue per patient, capacity expansion, and competitive dynamics with other Thai private hospitals (Bangkok Dusit Medical, Samitivej) and regional competitors (Singapore, Malaysia, India).